Baxter International Inc. (BAX)
Largest Insider Buys in Sector
BAX Stock Price History Chart
BAX Stock Performance
About Baxter International Inc.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Insider Activity of Baxter International Inc.
Over the last 12 months, insiders at Baxter International Inc. have bought $0 and sold $2.62M worth of Baxter International Inc. stock.
On average, over the past 5 years, insiders at Baxter International Inc. have bought $1.61M and sold $11.1M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 19,560 shares for transaction amount of $1.61M was made by Martin Sean (SVP and General Counsel) on 2020‑03‑30.
List of Insider Buy and Sell Transactions, Baxter International Inc.
| 2024-03-01 | Sale | EVP, Chief HR Officer | 64,488 0.0126% | $40.61 | $2.62M | -12.14% | ||
| 2023-02-21 | Sale | SVP, Chief Quality Officer | 3,813 0.0008% | $40.50 | $154,427 | -1.16% | ||
| 2023-01-17 | Sale | SVP, Human Resources | 59,477 0.0118% | $44.70 | $2.66M | -8.76% | ||
| 2022-04-05 | Sale | 1,215 0.0002% | $76.63 | $93,105 | -26.35% | |||
| 2022-04-05 | Sale | 2,827 0.0006% | $75.76 | $214,174 | -26.35% | |||
| 2022-04-01 | Sale | 1,005 0.0002% | $77.68 | $78,068 | -27.92% | |||
| 2022-03-01 | Sale | director | 1,005 0.0002% | $84.82 | $85,244 | -30.01% | ||
| 2022-02-28 | Sale | SVP, CAO and Controller | 2,500 0.0005% | $85.50 | $213,757 | -30.68% | ||
| 2022-02-14 | Sale | SVP, Human Resources | 54,143 0.0107% | $85.02 | $4.6M | -29.87% | ||
| 2022-02-02 | Sale | director | 1,680 0.0003% | $84.53 | $142,010 | -28.82% | ||
| 2022-02-01 | Sale | director | 1,005 0.0002% | $85.59 | $86,018 | -27.60% | ||
| 2021-11-01 | Sale | SVP and General Counsel | 21,450 0.0043% | $79.57 | $1.71M | -6.90% | ||
| 2021-08-02 | Sale | SVP and General Counsel | 19,800 0.004% | $77.26 | $1.53M | +2.66% | ||
| 2021-04-12 | Sale | SVP, President, APAC | 21,998 0.0044% | $84.79 | $1.87M | -3.28% | ||
| 2021-04-05 | Sale | director | 9,980 0.0013% | $57.91 | $577,942 | -3.92% | ||
| 2021-04-05 | Sale | director | 9,980 0.002% | $84.56 | $843,909 | -3.92% | ||
| 2020-11-02 | Sale | SVP and General Counsel | 94,002 0.0184% | $78.67 | $7.4M | +3.34% | ||
| 2020-09-14 | Sale | director | 620 <0.0001% | $57.42 | $35,604 | -2.99% | ||
| 2020-09-03 | Sale | SVP, Chief Quality Officer | 5,314 0.0011% | $85.87 | $456,313 | -3.32% | ||
| 2020-08-03 | Sale | director | 29,798 0.0061% | $86.41 | $2.57M | -1.96% |
Insider Historical Profitability
| Mason Jeanne K | EVP, Chief HR Officer | 142290 0.0279% | $30.89 | 0 | 9 | |
| Third Point LLC | director | 23008125 4.5062% | $30.89 | 0 | 5 | |
| Baxter Healthcare SA | 10 percent owner | 2603295 0.5099% | $30.89 | 1 | 0 | <0.0001% |
| KRAEMER HARRY M JANSEN JR | Chairman and | 694556 0.136% | $30.89 | 1 | 0 | +11.65% |
| PARKINSON ROBERT L JR | Chairman of the Board & CEO | 465485 0.0912% | $30.89 | 2 | 6 | +5.36% |
| TUCKER MICHAEL J | Senior Vice President | 187305 0.0367% | $30.89 | 0 | 1 | |
| ANDERSON BRIAN P | Senior Vice President and | 155427 0.0304% | $30.89 | 0 | 1 | |
| GATLING JAMES M | Corporate Vice President | 151660 0.0297% | $30.89 | 0 | 10 | |
| JEHARAJAH NEVILLE J | Corporate Vice President | 127603 0.025% | $30.89 | 1 | 0 | +8.11% |
| HURLEY JAMES R | Corporate Vice President | 120988 0.0237% | $30.89 | 0 | 1 | |
| Davis Robert M | Corporate Vice President | 120442 0.0236% | $30.89 | 0 | 3 | |
| GREISCH JOHN J | Corporate Vice President | 90419 0.0177% | $30.89 | 2 | 2 | +1.81% |
| HANTSON LUDWIG | Corporate Vice President | 83903 0.0164% | $30.89 | 0 | 3 | |
| Accogli Giuseppe | SVP, President, Americas | 66520 0.013% | $30.89 | 0 | 5 | |
| DROHAN DAVID F | Senior Vice President | 61879 0.0121% | $30.89 | 0 | 1 | |
| Eyre Brik V | SVP, President, Americas | 58993 0.0116% | $30.89 | 0 | 5 | |
| RIEDEL NORBERT G | Corporate Vice President | 52815 0.0103% | $30.89 | 0 | 7 | |
| Martin Sean | SVP and General Counsel | 42281 0.0083% | $30.89 | 1 | 3 | <0.0001% |
| Arduini Peter J | Corporate Vice President | 39855 0.0078% | $30.89 | 0 | 1 | |
| GAVIN JAMES R III | director | 39508 0.0077% | $30.89 | 0 | 8 | |
| Franzi Cristiano | SVP, President, EMEA | 39088 0.0077% | $30.89 | 0 | 1 | |
| DEL SALTO CARLOS | Corporate Vice President | 36289 0.0071% | $30.89 | 0 | 4 | |
| STROUCKEN ALBERT P L | 34127 0.0067% | $30.89 | 6 | 9 | +7.77% | |
| HELLMAN PETER S | 28822 0.0056% | $30.89 | 2 | 8 | +15.5% | |
| Baughman Michael J | Corporate Vice President | 27478 0.0054% | $30.89 | 0 | 3 | |
| Scharf David P. | Corporate Vice President | 27369 0.0054% | $30.89 | 0 | 3 | |
| FORSYTH JOHN D | 27029 0.0053% | $30.89 | 0 | 18 | ||
| McGillivray Bruce | Corporate Vice President | 26930 0.0053% | $30.89 | 0 | 2 | |
| FOSLER GAIL D | director | 25627 0.005% | $30.89 | 0 | 2 | |
| STORM KORNELIS J. | director | 22512 0.0044% | $30.89 | 0 | 6 | |
| BOOMER WALTER E | director | 21005 0.0041% | $30.89 | 0 | 2 | |
| Utts James E | Corporate Vice President | 20408 0.004% | $30.89 | 0 | 2 | |
| Pleau Scott | SVP, Operations | 20076 0.0039% | $30.89 | 0 | 3 | |
| White Cheryl L | Corporate Vice President | 16918 0.0033% | $30.89 | 0 | 1 | |
| Batchelor Phillip L. | Corporate Vice President | 17083 0.0033% | $30.89 | 0 | 4 | |
| Kunzler Jacqueline | SVP, Chief Quality Officer | 16725 0.0033% | $30.89 | 0 | 4 | |
| Devitt Blake E | director | 16541 0.0032% | $30.89 | 2 | 3 | +4.94% |
| Stevens Brian | SVP, CAO and Controller | 14011 0.0027% | $30.89 | 0 | 1 | |
| Chen Thomas F | director | 12987 0.0025% | $30.89 | 0 | 1 | |
| HOMBACH ROBERT J. | Corporate Vice President & CFO | 12612 0.0025% | $30.89 | 0 | 1 | |
| ALMEIDA JOSE E | Chairman of the Board and CEO | 11691 0.0023% | $30.89 | 1 | 0 | +11.44% |
| Shapazian Carole J | director | 9848 0.0019% | $30.89 | 0 | 20 | |
| Frye Andrew | SVP, President, APAC | 9041 0.0018% | $30.89 | 0 | 3 | |
| MARTIN JOSEPH B | director | 8637 0.0017% | $30.89 | 0 | 3 | |
| Bufalino Sebastian J | Corporate Vice President | 6275 0.0012% | $30.89 | 0 | 2 | |
| STALLKAMP THOMAS T | director | 4737 0.0009% | $30.89 | 0 | 14 |
Institutional Investor Ownership
| BlackRock | $2.61B | 11.96 | 60.96M | +2.15% | +$54.92M | 0.06 | |
| The Vanguard Group | $2.55B | 11.73 | 59.75M | -0.68% | -$17.42M | 0.05 | |
| Dodge & Cox | $1.18B | 5.4 | 27.5M | +0.44% | +$5.15M | 0.68 | |
| Voya Investment Management | $1.04B | 4.79 | 24.41M | +0.56% | +$5.78M | 3.58 | |
| State Street | $918.2M | 4.19 | 21.34M | -0.07% | -$618,256.08 | 0.04 | |
| T. Rowe Price | $712.73M | 3.27 | 16.68M | +1.69% | +$11.85M | 0.09 | |
| Ameriprise Financial | $650.46M | 2.99 | 15.22M | +36.41% | +$173.62M | 0.18 | |
| JPMorgan Chase | $496.09M | 2.28 | 11.61M | -5.66% | -$29.79M | 0.04 | |
| Geode Capital Management | $488.35M | 2.25 | 11.46M | +3.32% | +$15.7M | 0.04 | |
| Harris Associates | $426.22M | 1.96 | 9.97M | +7.75% | +$30.66M | 0.69 | |
| Generation Investment Management Llp | $383.84M | 1.76 | 8.98M | +7.86% | +$27.98M | 1.75 | |
| Macquarie Group | $331.69M | 1.52 | 7.76M | -6.55% | -$23.23M | 0.3 | |
| Invesco | $283.68M | 1.3 | 6.64M | -11.26% | -$35.99M | 0.06 | |
| State Farm | $266.06M | 1.22 | 6.23M | 0% | +$0 | 0.24 | |
| Northern Trust | $232.04M | 1.07 | 5.43M | -4.82% | -$11.75M | 0.04 | |
| Franklin Templeton Investments | $218.82M | 1.01 | 5.12M | +9.46% | +$18.9M | 0.07 | |
| Camber Capital Management Lp | $213.7M | 0.98 | 5M | 0% | +$0 | 7.53 | |
| Carmignac | $199.96M | 0.92 | 4.68M | -11.91% | -$27.03M | 3.18 | |
| Morgan Stanley | $191.88M | 0.88 | 4.49M | +1.27% | +$2.41M | 0.01 | |
| Artisan Partners | $188.59M | 0.87 | 4.41M | +6.89% | +$12.15M | 0.28 | |
| Fidelity Investments | $186.05M | 0.85 | 4.35M | +2.68% | +$4.85M | 0.01 | |
| Bank of America | $170.07M | 0.78 | 3.98M | -13.99% | -$27.67M | 0.02 | |
| BNY Mellon | $167.11M | 0.77 | 3.91M | -0.91% | -$1.53M | 0.03 | |
| Legal & General | $161.16M | 0.74 | 3.77M | -1.57% | -$2.57M | 0.04 | |
| Charles Schwab | $133.97M | 0.62 | 3.13M | +1.32% | +$1.74M | 0.03 | |
| CalPERS | $126.07M | 0.58 | 2.95M | -4.73% | -$6.25M | 0.09 | |
| Shapiro Capital Management Llc | $117.26M | 0.54 | 2.74M | -6.08% | -$7.59M | 2.7 | |
| Balyasny Asset Management Llc | $107.25M | 0.49 | 2.51M | New | +$107.25M | 0.29 | |
| Nordea Investment Management Ab | $105.09M | 0.48 | 2.46M | -5.59% | -$6.22M | 0.13 | |
| Fil Ltd | $104.95M | 0.48 | 2.46M | -10.46% | -$12.26M | 0.1 | |
| Goldman Sachs | $103.86M | 0.48 | 2.43M | -13.89% | -$16.75M | 0.02 | |
| Ubs Asset Management Americas Inc | $96.36M | 0.44 | 2.25M | -0.15% | -$148,094.10 | 0.03 | |
| Parnassus Investments Ca | $94.97M | 0.44 | 2.22M | 0% | +$0 | 0.2 | |
| Dimensional Fund Advisors | $93.44M | 0.43 | 2.19M | +5.6% | +$4.96M | 0.02 | |
| Maverick Capital Ltd | $90.6M | 0.42 | 2.12M | -2.59% | -$2.41M | 1.76 | |
| PointState Capital LP | $82.31M | 0.38 | 1.93M | -43.38% | -$63.07M | 2.49 | |
| Cooke & Bieler, L.P. | $81.86M | 0.38 | 1.92M | -7.85% | -$6.98M | 0.76 | |
| PLATINUM INVESTMENT MANAGEMENT LTD | $69.71M | 0.32 | 1.63M | 0% | +$0 | 0.92 | |
| Swiss National Bank | $64.93M | 0.3 | 1.52M | -4.06% | -$2.75M | 0.04 | |
| First Trust | $64.29M | 0.3 | 1.5M | -12.91% | -$9.53M | 0.07 | |
| Brandywine Global Investment Management | $62.56M | 0.29 | 1.46M | +5.29% | +$3.15M | 0.46 | |
| Amundi | $52.3M | 0.26 | 1.32M | -18.63% | -$11.97M | 0.02 | |
| Barclays | $55.05M | 0.25 | 1.29M | -16.42% | -$10.82M | 0.03 | |
| Russell Investments Group Ltd | $51.55M | 0.24 | 1.21M | +7.56% | +$3.62M | 0.07 | |
| Cullen Capital Management LLC | $51.54M | 0.24 | 1.21M | -2.23% | -$1.17M | 0.57 | |
| Edmond De Rothschild Holding S A | $51.22M | 0.24 | 1.2M | -1.71% | -$893,095.03 | 0.22 | |
| Sumitomo Mitsui Trust Holdings | $50.99M | 0.23 | 1.19M | -0.83% | -$425,604.92 | 0.03 | |
| Janus Henderson | $50.17M | 0.23 | 1.17M | -34.58% | -$26.52M | 0.03 | |
| Deutsche Bank | $49.23M | 0.23 | 1.15M | -19% | -$11.55M | 0.02 | |
| Nuveen | $48.2M | 0.22 | 1.13M | -0.29% | -$140,731.74 | 0.01 |